The Korean Journal of Medicine

  • 제84권2호
  • /
  • Pages.303-307
  • /
  • 2013
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Sunitinib 투여로 유발된 혈전성 혈소판 감소성 자반증 1예

A Case of Sunitinib-Associated Thrombotic Thrombocytopenic Purpura

  • 김은진 (울산대학교 의과대학 서울아산병원 내과) ;
  • 최윤미 (울산대학교 의과대학 서울아산병원 내과) ;
  • 이신원 (울산대학교 의과대학 서울아산병원 내과) ;
  • 하연정 (울산대학교 의과대학 서울아산병원 내과) ;
  • 이재련 (울산대학교 의과대학 서울아산병원 내과)
  • Kim, Eun Jin (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Yun Mi (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Sin Won (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ha, Yeon Jung (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Jae Lyun (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2012.05.17
  • 심사 : 2012.08.06
  • 발행 : 2013.02.01
⟨ 이전 논문 다음 논문 ⟩

초록

혈전성 혈소판 감소성 자반증 및 용혈성 요독성 증후군은 다발성 장기 손상 및 미세혈관병증 용혈빈혈을 보이는 급성 질환으로 치료하지 않을 경우 환자의 생명을 위협하는 치명적인 질환이다. 최근 VEGFR-TKI가 혈전성 혈소판 감소성 자반증을 유발할 수 있다는 보고가 나오고 있어, 저자들은 전이성 콩팥세포암종 환자에서 수니티닙을 사용한 뒤, 혈전성 혈소판 감소성 자반증이 발생한 1예를 경험하였기에 이를 보고하는 바이다.

Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (TTP-HUS) is an acute condition with abnormalities of multiple organ systems. It is characterized by microangiopathic hemolytic anemia and thrombocytopenia. Several chemotherapeutic agents have been implicated in causing TTP-HUS. We report a case of TTP-HUS during treatment with sunitinib in a patient with metastatic renal cell carcinoma. A 53-year-old woman visited our hospital for fever and cough. She was diagnosed with sunitinib-induced TTP. Discontinuation of sunitinib and plasmapheresis improved her TTP. When she experienced disease progression after a prolonged period without treatment, sorafenib was tried, resulting in a partial response without recurrence of TTP-HUS.

키워드

참고문헌

  1. Terrell DR, Williams LA, Vesely SK, Lämmle B, Hovinga JA, George JN. The incidence of thrombotic thrombocytopenic purpura-emolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-3 deficiency. J Thromb Haemost 2005;3:1432-1436. https://doi.org/10.1111/j.1538-7836.2005.01436.x
  2. Medina PJ, Sipols JM, George JN. Drug-ssociated thrombotic thrombocytopenic purpura-emolytic uremic syndrome. Curr Opin Hematol 2001;8:286-293. https://doi.org/10.1097/00062752-200109000-00004
  3. Talebi TN, Stefanovic A, Merchan J, Lian E, Silva O. Sunitinib-induced microangiopathic hemolytic anemia with fatal outcome. Am J Ther 2012;19:e143-145. https://doi.org/10.1097/MJT.0b013e3181eefe8b
  4. Kapiteijn E, Brand A, Kroep J, Gelderblom H. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. Ann Oncol 2007;18:1745-1747. https://doi.org/10.1093/annonc/mdm454
  5. Papaetis GS, Syrigos KN. Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies. BioDrugs 2009;23:377-389. https://doi.org/10.2165/11318860-000000000-00000
  6. Frangie C, Lefaucheur C, Medioni J, Jacquot C, Hill GS, Nochy D. Renal thrombotic microangiopathy caused by anti-EGF-ntibody treatment for metastatic renal-ell carcinoma. Lancet Oncol 2007;8:177-178. https://doi.org/10.1016/S1470-2045(07)70037-2
  7. Choi MK, Hong JY, Jang JH, Lim HY. TTP-US associated with sunitinib. Cancer Res Treat 2008;40:211-213. https://doi.org/10.4143/crt.2008.40.4.211
  8. Nzerue CM. Thrombotic microangiopathies. N Engl J Med 2002;347:2171-2173. https://doi.org/10.1056/NEJM200212263472616
  9. Franchini M, Montagnana M, Targher G, Lippi G. Reduced von Willebrand factor-leaving protease levels in secondary thrombotic microangiopathies and other diseases. Semin Thromb Hemost 2007;33:787-797. https://doi.org/10.1055/s-2007-1000365
  10. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008;358:1129-1136. https://doi.org/10.1056/NEJMoa0707330